5,444 reports of this reaction
3.6% of all DULAGLUTIDE reports
#5 most reported adverse reaction
INCORRECT DOSE ADMINISTERED is the #5 most commonly reported adverse reaction for DULAGLUTIDE, manufactured by Eli Lilly and Company. There are 5,444 FDA adverse event reports linking DULAGLUTIDE to INCORRECT DOSE ADMINISTERED. This represents approximately 3.6% of all 151,183 adverse event reports for this drug.
Patients taking DULAGLUTIDE who experience incorrect dose administered should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
INCORRECT DOSE ADMINISTERED is moderately reported among DULAGLUTIDE users, representing a notable but not dominant share of adverse events.
In addition to incorrect dose administered, the following adverse reactions have been reported for DULAGLUTIDE:
The following drugs have also been linked to incorrect dose administered in FDA adverse event reports:
INCORRECT DOSE ADMINISTERED has been reported as an adverse event in 5,444 FDA reports for DULAGLUTIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
INCORRECT DOSE ADMINISTERED accounts for approximately 3.6% of all adverse event reports for DULAGLUTIDE, making it a notable side effect.
If you experience incorrect dose administered while taking DULAGLUTIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.